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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S416shorter period of hospitalization than M5; however, there was no sig-
niﬁcant difference between M10 and P.
Conclusions: In conclusion, the research shows that there is a notice-
able effect of multimodal drug cocktail on ROM rehabilitation and pain
control. However, it is difﬁcult to see any clear effects of the drugs on
ability to walk. I believe that this could be due to preexisting conditions
(preoperative) that restrict the patients’ potential to walk.
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PAIN MECHANISMS IN OA: QUANTITATIVE SENSORY TESTING AND
PATIENT REPORTED OUTCOMES
K. Phillips. Univ. of Michigan, Ann Arbor, MI, United States
Purpose: Arthritis pain symptoms do not correlate with radiographic
damage in knee osteoarthritis, and central pain sensitization (neuro-
biological alterations in pain signaling) may play a role in some patients.
Some patients with chronic OA have suboptimal pain relief and the co-
morbid prevalence of pain sensitivity phenotypes in OA patients is
unknown. Prospective studies may help identify predictors of sub-
optimal pain management, and a composite index may be useful as part
of an initial assessment.
Methods: The SOAR (Pain sensitivity in osteoarthritis research) cohort
is a prospective, longitudinal study of patients with chronic knee pain
and radiographic osteoarthritis. At baseline, patients completed self-
report questionnaires, including the PainDETECT survey, Brief Pain
Inventory, and a body map. Quantitative sensory testing and con-
ditioned pain modulation was evaluated using the MAST device.
Descriptive statistics and correlational analyses examined the results.
Results: 60 patients were enrolled at the time of the evaluation;
enrollment is ongoing for this cohort. Patient scores on pain assess-
ments were normally distributed. Pain scores did not correlate with
radiographic severity. A composite index score for centrally mediated
pain was directly correlated with baseline pain intensity and neuro-
pathic pain complaints, Differences were noted in pressure pain
thresholds between men and women, but no gender differences were
seen in conditioned pain modulation. The impact of caffeine intake on
QST results was assessed.
Conclusions: In a medically managed cohort of patients with knee
osteoarthritis, radiographic indices did not correlate with pain scores.
A higher composite index score of centrally mediated pain com-
plaints and symptoms was correlated with self-report of higher pain
and more neuropathic pain descriptors. Future studies on predictors
of pressure pain thresholds and limited conditioned pain modulation
may help identify patients who preferentially respond to targeted
therapies.Pain: Pathophysiology
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DAMPS PROVIDE A LINK BETWEEN JOINT TISSUE DAMAGE AND PAIN
THROUGH DIRECT ACTIVATION OF TLR4 EXPRESSED BY SENSORY
NEURONS
R.E. Miller y, P.B. Tran y, S. Ishihara y, R.J. Miller z, A.-M. Malfait y. yRush
Univ. Med. Ctr., Chicago, IL, United States; zNorthwestern Univ., Chicago,
IL, United States
Purpose: Damage-associated molecular patterns (DAMPs) are gen-
erated in the joint during the course of osteoarthritis (OA). These
DAMPs have been shown to activate pattern recognition receptors (PRR,
such as TLRs and RAGE) on chondrocytes and synovial macrophages,
thus promoting cartilage degradation and synovitis in OA. Here, we
hypothesized that DAMPs may directly activate nociceptors through
TLR4. We thus investigated the effects of S100A8 and a2-macroglobulin
on cultured sensory neurons and tested the effects of blocking toll-like
receptor (TLR)4, using the destabilization of the medial meniscus
(DMM) surgical model.
Methods: Knee innervating dorsal root ganglia (DRG) neurons (L3–L5)
were isolated from naïve C57BL/6 mice (at least 10 weeks of age), plated
on coverslips, and cultured in neurogenic medium for either (1) calciummobilization, or (2) stimulation assays. For calcium mobilization assays,
cultures were loaded with a ﬂuorescent calcium indicator dye on day 4,
and responses to S100A8 (1 mg/mL) or a2-macroglobulin (50 mg/mL)
were recorded. For stimulation assays, cultures were treated overnight
with S100A8 (1 mg/mL) or a2-macroglobulin (50 mg/mL), with or
without the selective TLR4 inhibitor, TAK242 (Tocris, 1 mM). Super-
natants were collected for ELISA analysis of the pro-algesic chemokine,
MCP-1. We chose release of MCP-1 as a marker of activation because we
have previously shown that this is an important mediator of pain in this
model.
DMM or sham surgery was performed in the right knees of 10-week old
male C57BL/6 mice. A set of n ¼ 4 mice/group were taken down at 8 or
16 weeks post surgery and knee-innervating DRG L3-L5 were harvested
for culture of sensory neurons as above with or without the TLR4
inhibitor. After 4 days, culture supernatants were analyzed for MCP-1
protein levels via ELISA. Additional mice were perfused at 8 weeks post
surgery for immunohistochemistry of the DRG (L2-L5) using anti-TLR4
(Abcam).
Results: Naïve DRG neurons rapidly responded to S100A8 as
indicated by increased calcium mobilization, suggesting that DRG
neurons expressed excitatory receptors for this protein. In addi-
tion, overnight stimulation with S100A8 resulted in 6-fold upre-
gulation in MCP-1 protein production compared to unstimulated
neurons (p < 0.0001), which is on par with the effects of TNF-a or
IL-1. A small molecule TLR4 inhibitor was able to signiﬁcantly
decrease the ability of S100A8 to stimulate MCP-1 production (p <
0.01) (Fig 1).
a2-macroglobulin was also able to induce calcium mobilization
responses in naove DRG neurons. In addition, overnight stimulation
resulted in a 1.3-fold upregulation of MCP-1 protein production (p ¼
0.12 compared to unstimulated neurons). Again, blocking TLR4
decreased this MCP-1 upregulation (p < 0.05).
At 8 and 16 weeks post DMM, unstimulated DRG neurons produced
increased amounts of MCP-1 compared to age-matched naïve and sham
DRG neurons. Including a small-molecule selective TLR4 inhibitor in the
culture medium signiﬁcantly reduced the amount of MCP-1 produced
by the DMM DRG cells at both time points (Fig 2).
Finally, immunohistochemistry of the innervating DRG showed that
TLR4 expression increased at 8 weeks post DMM, compared to age-
matched naïve DRG.
Conclusions: These studies suggest that sensory neurons have the
ability to respond to tissue damage products produced during the
course of progressive osteoarthritis, and that this pathway may play a
role in the initiation and maintenance of osteoarthritis-associated
pain.
